Skip to main content
CSL
  • Global Selector
  • Newsroom
  • Partnering
  • Contact
  • We Are CSL
    We Are CSL
    Our Businesses and Products
    Vita: Original Stories
    Our Leadership
    Worldwide Locations
    Corporate Governance
    Our Impact
    Frequently Asked Questions (FAQs)
    Our Businesses and Products
    CSL Behring
    CSL Seqirus
    CSL Vifor
    Corporate Governance
    Code of Conduct
    Core Policies

    Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.

    Read the Stories

    CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.

    Our Businesses and Products
  • Patients & Public Health
    Patients & Public Health
    Rare & Serious Diseases
    Iron Deficiency
    Nephrology
    Vaccines
    Patient Support & Organizations
    Rare & Serious Diseases
    Immunodeficiency and Autoimmune Diseases
    Hereditary Bleeding Disorders
    Hereditary Angioedema
    Alpha 1 Antitrypsin Deficiency
    Iron Deficiency
    Iron Deficiency Patient Stories
    Nephrology
    Nephrology Patient Stories
    Vaccines
    COVID-19
    Pandemic Response
    In-Licensing
    Antivenoms and Q fever Vaccine
    Patient Support & Organizations
    CSL Behring USA Support & Assistance Programs
    CSL Vifor Managed Access Programs
    LEAD Grants
    CSL Community Impact Awards

    Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.

    CSL Behring: Rare & Serious Diseases

    Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.

    CSL Seqirus: Vaccines
  • R&D
    R&D
    R&D Capabilities
    Awards, Grants and Initiatives
    World-Class R&D Network
    Product Pipeline
    Clinical Studies at CSL
    Clinical Studies at CSL
    Current Clinical Trials
    Research Practices
    How to Participate
    Clinical Studies FAQs

    R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.

    R&D Capabilities

    One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.

    Awards, Grants and Initiatives
  • Sustainability
    Sustainability
    Healthier Environment
    Healthier Communities
    Promising Futures
    Governance
    Data and Reporting Centre
    Healthier Environment
    Climate Resilience
    Energy
    Water, Waste & Biodiversity
    Healthier Communities
    Product Safety & Quality
    Innovation and R&D
    Access and Affordability
    Responsible & Resilient Supply Chain
    Donor Experience
    Patient Experience
    Promising Futures
    Talent and Culture
    Health, Safety & Wellbeing
    Inclusion and Belonging
    Governance
    Ethics & Transparency
    Data Protection & Privacy
    Stakeholder Engagement & Material Topics
    Data and Reporting Centre
    Annual Publications
    Policies
    Key Performance Data Summary

    As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.

    Learn About Our Targets

    Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.

    Supporting Our Communities
  • Careers
    Careers
    Inclusion and Belonging
    How CSL Supports Your Well-being
    Early Careers at CSL
    Life at CSL
    Explore Careers at CSL
    Early Careers at CSL
    Apprenticeships
    Internships at CSL
    Graduate Rotational Programs at CSL

    At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.

    Read About Our Approach to Inclusion and Belonging

    Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!

    Early Careers at CSL
  • Investors
CSL

  • We Are CSL
    • We Are CSL
    • Our Businesses and Products
      • Our Businesses and Products
      • CSL Behring
      • CSL Seqirus
      • CSL Vifor
    • Vita: Original Stories
    • Our Leadership
    • Worldwide Locations
    • Corporate Governance
      • Corporate Governance
      • Code of Conduct
      • Core Policies
    • Our Impact
    • Frequently Asked Questions (FAQs)
  • Patients & Public Health
    • Patients & Public Health
    • Rare & Serious Diseases
      • Rare & Serious Diseases
      • Immunodeficiency and Autoimmune Diseases
      • Hereditary Bleeding Disorders
      • Hereditary Angioedema
      • Alpha 1 Antitrypsin Deficiency
    • Iron Deficiency
      • Iron Deficiency
      • Iron Deficiency Patient Stories
    • Nephrology
      • Nephrology
      • Nephrology Patient Stories
    • Vaccines
      • Vaccines
      • COVID-19
      • Pandemic Response
      • In-Licensing
      • Antivenoms and Q fever Vaccine
    • Patient Support & Organizations
      • Patient Support & Organizations
      • CSL Behring USA Support & Assistance Programs
      • CSL Vifor Managed Access Programs
      • LEAD Grants
      • CSL Community Impact Awards
  • R&D
    • R&D
    • R&D Capabilities
    • Awards, Grants and Initiatives
    • World-Class R&D Network
    • Product Pipeline
    • Clinical Studies at CSL
      • Clinical Studies at CSL
      • Current Clinical Trials
      • Research Practices
      • How to Participate
      • Clinical Studies FAQs
  • Sustainability
    • Sustainability
    • Healthier Environment
      • Healthier Environment
      • Climate Resilience
      • Energy
      • Water, Waste & Biodiversity
    • Healthier Communities
      • Healthier Communities
      • Product Safety & Quality
      • Innovation and R&D
      • Access and Affordability
      • Responsible & Resilient Supply Chain
      • Donor Experience
      • Patient Experience
    • Promising Futures
      • Promising Futures
      • Talent and Culture
      • Health, Safety & Wellbeing
      • Inclusion and Belonging
    • Governance
      • Governance
      • Ethics & Transparency
      • Data Protection & Privacy
      • Stakeholder Engagement & Material Topics
    • Data and Reporting Centre
      • Data and Reporting Centre
      • Annual Publications
      • Policies
      • Key Performance Data Summary
  • Careers
    • Careers
    • Inclusion and Belonging
    • How CSL Supports Your Well-being
    • Early Careers at CSL
      • Early Careers at CSL
      • Apprenticeships
      • Internships at CSL
      • Graduate Rotational Programs at CSL
    • Life at CSL
    • Explore Careers at CSL
  • Investors
  • Newsroom
  • Partnering
  • Contact
  • Global Selector

CSL's 2026 Half Year Financial Results

We have announced our 2026 Half Year Financial Results for the period ending 31st December 2025.

View Announcement and Webcast Information

Like to learn more about Our Impact? Click here to view or download the 2025 Impact Report →   |    Would you like to read our 2025 Annual Report? Click here to view or download the Annual Report →   |    CSL's 2025 Full Year Financial Results Click here for Full Information including Webcast Recording →

CSL
CSL Behring
CSL Seqirus
CSL Vifor

CSL. Always Evolving for a Better World.

CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.

Our Businesses and Products

CSL Behring. Leading the Way in Treating Rare and Serious Diseases.

CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.

More About CSL Behring

CSL Seqirus. Global Vaccine Leader.

Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.

More About CSL Seqirus

CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.

The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.

More About CSL Vifor
CSL Logo The text 'CSL' in bold white all capitals.
CSL Behring Logo The text 'CSL Behring' in bold white.
CSL Seqirus Logo The text 'CSL Seqirus' in bold white.
CSL Vifor Logo The text 'CSL Vifor' in bold white.
CSL Logo

CSL. Always Evolving for a Better World.

CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.

Our Businesses and Products
CSL Behring Logo

CSL Behring. Leading the Way in Treating Rare and Serious Diseases.

CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.

More About CSL Behring
CSL Seqirus Logo

CSL Seqirus. Global Vaccine Leader.

Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.

More About CSL Seqirus
CSL Vifor Logo

CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.

The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.

More About CSL Vifor

Vita: Original Stories

'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.

CSL-sponsored light display at Philadelphia's Boathouse Row on Rare Disease Day 2026

Video: See the Lights of Rare Disease Day 2026

Watch video footage of displays in Philadelphia and Marburg, Germany. CSL supports the Global Chain of Lights to honor the mi…

03 Mar 2026
Philadelphia's historic Boathouse Row lit up for Rare Disease Day 2025

Lighting Up a Philly Landmark for Rare Disease Day

The boathouses along the Schuylkill River date back to the 1800s. Today, they shine at night thanks to a 21st century LED lig…

26 Feb 2026
A woman who's sick in bed during the daytime. A screenshot of the new website SickonRepeat.com

Are You Sick on Repeat?

CSL launches SickonRepeat.com to raise awareness about the symptoms of primary immunodeficiency, a condition that results in …

26 Feb 2026
CSL scientist in Switzerland

Careers at CSL

We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?

Pictured: A CSL employee in Bern, Switzerland

Promising Futures at CSL

CSL on LinkedIn

Follow us!
LinkedIn
3 Mar

Sustainability at CSL goes beyond environmental goals; it’s about advancing global health equity and strengthening communities. From responsible manufacturing to partnerships that expand access to care, we’re committed to impact that lasts. Join a company built on responsibility and purpose: csl.com/careers #CSLCareers #Sustainability #SocialResponsibility #GlobalImpact #CSL

LinkedInPostImage
LinkedIn
3 Mar

Sustainability at CSL goes beyond environmental goals; it’s about advancing global health equity and strengthening communities. From responsible manufacturing to partnerships that expand access to care, we’re committed to impact that lasts. Join a company built on responsibility and purpose: https://bit.ly/4u3q0Na #CSLCareers #Sustainability #SocialResponsibility #GlobalImpact #CSL

LinkedInPostImage
LinkedIn
3 Mar

We are proud to announce that Karine Levesque has been appointed Co-President of Alliance Plasma  France.  Launched in 2025, Alliance Plasma brings together patient associations, specialized laboratories, and key stakeholders to strengthen the plasma value chain and deliver sustainable, patient-centered solutions.  We congratulate Karine on this appointment and look forward to her leadership in advancing collaboration and ensuring patients have access to the therapies they need.  Learn more: https://lnkd.in/g8bAMXsM   #CSL #CSLPlasma #CSLFrance

LinkedInPostImage
LinkedIn
2 Mar

💜🩷💙💚 Lighting up landmarks worldwide! Rare Disease Day 2026 brought millions of people together worldwide to spotlight the realities faced by those living with rare diseases. Here are some of the places CSL helped illuminate in the colors of #RareDiseaseDay to help raise awareness. https://lnkd.in/e68zd2es   #CSL #RareDisease #RDD #Marburg #Bern #Philadelphia #Kankakee  

LinkedIn
9 Feb

Rare Disease Day is February 28th. To shine a light on those battling rare diseases, today we’re highlighting von Willebrand Disease or \(VWD\). According to the CDC, von Willebrand Disease is the most common blood disorder. https://lnkd.in/gZZmTNHx #CSL #RareDiseaseDay #RDD #VWD #VonWillebrandDisease

LinkedIn
28 Feb

💙💚RARE DISEASE DAY! 💜🩷 We’re lighting up landmarks around the world in honor of #RareDiseaseDay ! Tonight, the Old University in Marburg is illuminated in the colors of Rare Disease Day and joins the global light chain. The illumination of the Old University in Marburg is a visible symbol of this commitment and reinforces our mission to bring visibility to rare diseases. We are proud to be part of this worldwide initiative, helping ensure that those living with rare diseases are seen, heard, and supported. https://lnkd.in/eshfukXQ #RareDiseaseDay #CSL #CSLBehring #RareButNotAlone #RareDiseases #Awareness #Marburg #Germany

LinkedIn
11 Feb

CSL is the world’s only maker of antivenoms for many native venomous Australian species. Click the link to learn more about how we are serving a significant public health need: csl.com/impact #CSL #CSLImpactReport #Antivenom #Seqirus

LinkedIn
27 Feb

If you're in the #Philadelphia area, watch out for a special light display on #RareDiseaseDay . The historic boathouses along the Schuylkill River will glow for the 300 million people worldwide who live with a #raredisease . https://lnkd.in/eDtXNh3X #GlobalChainofLight

LinkedIn
26 Feb

Rare disease patient \(and new author\) Jodi Taub shares 3 reasons #RareDiseaseDay is important to her. #primaryimmunodeficiency #MoreThanAPatient #raredisease

LinkedIn
25 Feb

Career growth at CSL is shaped by learning, connection and supportive teams. From hands-on training to opportunities across science, quality and operations, employees build careers rooted in purpose and possibility. Discover a culture that helps you grow: https://lnkd.in/e7vgM2e2 #CSLCareers #LifeAtCSL #CareerGrowth #PromisingFutures #CSL

We Are CSL

  • Our Businesses and Products
  • Vita: Original Stories
  • Our Leadership
  • Worldwide Locations
  • Corporate Governance
  • Our Impact
  • Frequently Asked Questions (FAQs)

Patients & Public Health

  • Rare & Serious Diseases
  • Iron Deficiency
  • Nephrology
  • Vaccines
  • Patient Support & Organizations

R&D

  • R&D Capabilities
  • Awards, Grants and Initiatives
  • World-Class R&D Network
  • Product Pipeline
  • Clinical Studies at CSL

Sustainability

  • Healthier Environment
  • Healthier Communities
  • Promising Futures
  • Governance
  • Data and Reporting Centre

Careers

  • Inclusion and Belonging
  • How CSL Supports Your Well-being
  • Early Careers at CSL
  • Life at CSL
  • Explore Careers at CSL

Investors

Terms of Use Cookie Policy Global Privacy Policy Accessibility Statement Sitemap
  • Terms of Use
  • Cookie Policy
  • Global Privacy Policy
  • Accessibility Statement
  • Sitemap
CSL logo

CSL, All Rights Reserved © 2026

  • Instagram

CSL
  • CSL (CSL Behring's Parent Company)
CSL Behring Worldwide

Americas

  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Mexico

Asia Pacific

  • Australia
  • China
  • Japan
  • Korea
  • Singapore
  • Taiwan

Middle East

  • Saudi Arabia
  • United Arab Emirates (MEA)

Europe

  • Austria
  • Belgium and Luxembourg
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
CSL Plasma (CSL Behring Subsidiary)
  • CSL Plasma US
  • CSL Plasma Germany
  • CSL Plasma Hungary